Key result
A 28-year-old immunocompetent man with cardiogenic shock secondary to tuberculous myopericarditis successfully recovered with normal left ventricular systolic function after 9 months of antituberculosis therapy and steroids.
Case Report (n=1)
Tuberculous myopericarditis is a rare but reversible cause of cardiogenic shock that can be successfully treated with antituberculosis therapy, steroids, and heart failure management.
Supports inclusion of tuberculous myopericarditis in cardiogenic shock differentials; leaves open steroid efficacy in prospective studies.
Tuberculosis is a common cause of pericardial disease in India. Myocardial involvement, although well described in the literature, is a rare manifestation of tuberculosis. We report a patient with disseminated tuberculosis and myopericarditis manifesting as cardiogenic shock. The patient gradually improved on antituberculosis drug therapy, steroids and an evidence-based guideline driven therapy for heart failure. Follow-up imaging showed calcification of the pericardium and improvement of his left ventricular systolic function.
No takes yet. Share an insight, caveat, or question.
Desai et al. (2013) conducted a case report in Tuberculous myopericarditis (n=1). Antituberculosis drug therapy and steroids was evaluated on Clinical and echocardiographic improvement. A 28-year-old immunocompetent man with cardiogenic shock secondary to tuberculous myopericarditis successfully recovered with normal left ventricular systolic function after 9 months of antituberculosis therapy and steroids.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: